why choose us

First received: June 06, 2023

Clinical Trial: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Independent of HER2 Expression With Progression After Previous Treatment

Brief Summary: This Clinical Trial is investigating the potential efficacy of axitinib after genetic testing in BRCA 1/2 Mutation patients, regardless of HER2 expression, who have progressed after at least one line of standard treatment or for whom there is no consensus treatment approach.The use of Axitinib may help physicians plan for more effective patient care in combination with existing treatment protocols.

Read more